As of December 2024, Kymera Therapeutics has a market cap of $2.32B. This makes Kymera Therapeutics the world's 4700th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.22B | 46.54% |
2023 | $1.51B | 2.00% |
2022 | $1.48B | -60.69% |
2021 | $3.77B | 2.40% |
2020 | $3.68B | - |